Liver drug developer Jecure acquired by Genentech

Liver drug developer Jecure acquired by Genentech

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

Jecure Therapeutics, a San Diego company targeting inflammatory liver diseases, said Tuesday it has agreed to be purchased by Genentech. The purchase price wasn?t disclosed.

Privately held Jecure was founded in 2015 with financing from Versant Ventures. The company raised $20 million from Versant…